Thatte U M, Kulkarni-Munshi R, Kalekar S A
Deparment of Clinical Pharmacology, TN Medical College and BYL Nair Charitable Hospital, Mumbai Central, Mumbai, India.
J Med Ethics. 2009 Feb;35(2):133-9. doi: 10.1136/jme.2008.025155.
As there is little Indian data about severity, frequency and types of research related injuries, costs involved and policies regarding compensation, this study was conducted to review the present Indian scenario.
The study was carried out in three parts; a questionnaire-based survey, in-depth interviews, and a review of informed consent and insurance documents of projects submitted to three ethics committees.
47% of investigators were either unaware of, or had not understood, the legal requirements and depended on sponsors to manage these issues, whereas 74% of ethics committee members were aware of the requirements. Although 40% of investigators, 30% of ethics committee members and all sponsors had policies to manage compensation issues, these were mainly to provide immediate free medical care or reimbursement of expenses incurred for the acute management of an adverse event. Compensation for loss of time/wages, death, physical disability or long term incapacitation was not included. A review of informed consent and insurance documents showed that compensation issues were inadequately discussed, with only insurance certificates submitted to ethics committees.
In India, there are no uniform policies and investigators are largely unaware of their responsibilities. Therefore, there is an urgent need to draft national guidelines regarding compensation for research injuries of research participants and highlight the responsibilities of each stakeholder. Potential research injuries should be categorised based on risk assessment, severity and seriousness of the injury. Further, it would be necessary to have arbitration committees to determine the extent of compensation. Training and awareness workshops for those involved in clinical research, including research participants, is also needed.
由于印度关于研究相关伤害的严重程度、发生频率和类型、所涉及的费用以及赔偿政策的数据很少,因此开展了本研究以审视印度目前的情况。
该研究分三个部分进行;基于问卷的调查、深入访谈,以及对提交给三个伦理委员会的项目的知情同意书和保险文件的审查。
47%的研究者要么不知道,要么没有理解法律要求,而是依赖申办者来处理这些问题,而74%的伦理委员会成员知晓这些要求。尽管40%的研究者、30%的伦理委员会成员和所有申办者都有处理赔偿问题的政策,但这些政策主要是提供即时的免费医疗护理或报销不良事件急性处理所产生的费用。不包括对误工/工资损失、死亡、身体残疾或长期无行为能力的赔偿。对知情同意书和保险文件的审查表明,赔偿问题讨论不充分,提交给伦理委员会的只有保险证书。
在印度,没有统一的政策,研究者很大程度上不知道自己的责任。因此,迫切需要起草关于研究参与者研究伤害赔偿的国家指南,并明确每个利益相关者的责任。应根据风险评估、伤害的严重程度和严重性对潜在的研究伤害进行分类。此外,有必要设立仲裁委员会来确定赔偿范围。还需要为参与临床研究的人员,包括研究参与者,举办培训和提高认识的研讨会。